Afrezza

Technosphere insulin · MannKind Corporation

Drug timelines are a Plus or Pro feature.

40 regulatory and trial events tracked for Afrezza, covering 2009-07-08 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes [Phase 2]